Literature DB >> 17894133

Management of type 2 diabetes in youth: an update.

Kevin Peterson1, Janet Silverstein, Francine Kaufman, Elizabeth Warren-Boulton.   

Abstract

Although type 1 diabetes historically has been more common in patients eight to 19 years of age, type 2 diabetes is emerging as an important disease in this group. Type 2 diabetes accounts for 8 to 45 percent of new childhood diabetes. This article is an update from the National Diabetes Education Program on the management of type 2 diabetes in youth. High-risk youths older than 10 years have a body mass index greater than the 85th percentile for age and sex plus two additional risk factors (i.e., family history, high-risk ethnicity, acanthosis nigricans, polycystic ovary syndrome, hypertension, or dyslipidemia). Reducing overweight and impaired glucose tolerance with increased physical activity and healthier eating habits may help prevent or delay the development of type 2 diabetes in high-risk youths. The American Academy of Pediatrics does not recommend population-based screening of high-risk youths; however, physicians should closely monitor these patients because early diagnosis may be beneficial. The American Diabetes Association recommends screening high-risk youths every two years with a fasting plasma glucose test. Patients diagnosed with diabetes should receive self-management education, behavior interventions to promote healthy eating and physical activity, appropriate therapy for hyperglycemia (usually metformin and insulin), and treatment of comorbidities.

Entities:  

Mesh:

Year:  2007        PMID: 17894133

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  5 in total

1.  Do obese children with diabetic ketoacidosis have type 1 or type 2 diabetes?

Authors:  Joey C Low; Eric I Felner; Andrew B Muir; Milton Brown; Margalie Dorcelet; Limin Peng; Guillermo E Umpierrez
Journal:  Prim Care Diabetes       Date:  2012-01-09       Impact factor: 2.459

2.  Success with lifestyle monotherapy in youth with new-onset type 2 diabetes.

Authors:  Kristy Dm Wittmeier; Brandy A Wicklow; Elizabeth Ac Sellers; Angella Tr Griffith; Heather J Dean; Jonathan M McGavock
Journal:  Paediatr Child Health       Date:  2012-03       Impact factor: 2.253

Review 3.  Depression and quality of life in youth-onset type 2 diabetes mellitus.

Authors:  Natalie Walders-Abramson
Journal:  Curr Diab Rep       Date:  2014-01       Impact factor: 4.810

4.  Cardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms.

Authors:  Nancy A West; Richard F Hamman; Elizabeth J Mayer-Davis; Ralph B D'Agostino; Santica M Marcovina; Angela D Liese; Philip S Zeitler; Stephen R Daniels; Dana Dabelea
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 17.152

5.  METFORMIN: an efficacy, safety and pharmacokinetic study on the short-term and long-term use in obese children and adolescents - study protocol of a randomized controlled study.

Authors:  Marloes P van der Aa; Marieke A J Elst; Edgar G A H van Mil; Catherijne A J Knibbe; Marja M J van der Vorst
Journal:  Trials       Date:  2014-06-05       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.